Ni-Chun Tsai Selected Research

Ni-Chun Tsai Research Topics

Disease

7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2016
6	Hodgkin Disease (Hodgkin's Disease) 04/2024 - 06/2012
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 11/2009
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2024 - 09/2010
4	Multiple Myeloma 01/2020 - 01/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 12/2019
2	Neoplasms (Cancer) 01/2024 - 10/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2021
2	Leukemia 01/2022 - 04/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2018 - 01/2016
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 08/2017
1	Osteoarthritis 01/2024
1	Pain (Aches) 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Joint Diseases (Joint Disease) 01/2024
1	Arthralgia (Joint Pain) 01/2024
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023
1	Disease Progression 01/2023
1	COVID-19 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Bacteremia 12/2021
1	Rheumatoid Arthritis 01/2020
1	Pathologic Complete Response 01/2020
1	Venous Thromboembolism 01/2019
1	Residual Neoplasm 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Lymphoma (Lymphomas) 12/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2011
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2011

Drug/Important Bio-Agent (IBA)

5	Sirolimus (Rapamycin)FDA Link 01/2023 - 01/2016
5	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 12/2014
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2014
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 01/2016
4	fludarabineIBA 01/2022 - 01/2020
4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 12/2014
3	Brentuximab VedotinIBA 04/2024 - 06/2012
3	plerixafor FDA Link 09/2017 - 01/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2017 - 12/2014
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2018 - 08/2017
2	Rituximab (Mabthera)FDA Link 01/2018 - 08/2017
2	ibritumomab tiuxetan (Zevalin)FDA Link 06/2017 - 12/2014
2	Yttrium-90IBA 06/2017 - 12/2014
2	Carmustine (FIVB)FDA Link 06/2017 - 12/2014
1	midostaurinIBA 04/2024
1	ibrutinibIBA 04/2024
1	monomethyl auristatin EIBA 04/2024
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Aromatase InhibitorsIBA 01/2024
1	CurcuminIBA 01/2024
1	relugolixIBA 01/2023
1	AndrogensIBA 01/2023
1	Inotuzumab OzogamicinIBA 01/2023
1	ruxolitinibIBA 01/2022
1	NivolumabIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	IceIBA 01/2022
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	AntithrombinsIBA 01/2019
1	pegaspargase (Oncaspar)FDA Link 01/2019
1	pomalidomideIBA 07/2018
1	ixazomibIBA 07/2018
1	Lenalidomide (CC 5013)FDA Link 07/2018
1	Cyclin D1IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 08/2017
1	Prednisone (Sone)FDA LinkGeneric 08/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017
1	Bendamustine Hydrochloride FDA Link 08/2017
1	N 30IBA 10/2011

Therapy/Procedure

12	Cell Transplantation 01/2023 - 10/2011
6	Drug Therapy (Chemotherapy) 04/2024 - 11/2009
6	Therapeutics 01/2024 - 10/2011
4	Hematopoietic Stem Cell Transplantation 12/2019 - 01/2016
3	Transplantation 01/2023 - 01/2016
3	Homologous Transplantation 01/2022 - 06/2012
3	Stem Cell Transplantation 01/2018 - 09/2010
2	Lymphatic Irradiation 01/2022 - 04/2017
2	Salvage Therapy 01/2022 - 12/2021
2	Radioimmunotherapy 12/2021 - 03/2012
1	Catheters 12/2021
1	Autologous Transplantation 12/2014
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2009